INFIGRATINIB 25 MG/ 100 MG TABLET

🧪 Composition

• Active Ingredient: Infigratinib
• Dosage Form: Oral Capsule
• Available Strengths: 25 mg, 100 mg

✅ Uses

• Used for the treatment of previously treated, unresectable or metastatic cholangiocarcinoma (bile duct cancer) with FGFR2 fusion or rearrangement.
• Helps slow the growth and spread of cancer cells.
• Supports disease control in patients with eligible FGFR2 genetic alterations.
• Used as part of a personalized treatment plan based on genetic testing.

💉 Dosage

Take Infigratinib exactly as prescribed by your healthcare provider. The dosage depends on the patient’s medical condition, treatment response, and laboratory findings. Swallow the capsules whole with water and follow the prescribed treatment schedule. Do not change the dose or discontinue therapy without medical advice.

⚠️ Precautions

• Use only under the supervision of a qualified healthcare professional.
• Regular monitoring of phosphate levels, kidney function, liver function, and eye health may be required during treatment.
• Inform your doctor about any eye disorders, kidney disease, liver disease, or other existing medical conditions before starting therapy.
• Report symptoms such as vision changes, severe fatigue, muscle cramps, or persistent gastrointestinal problems immediately.

📦 Storage

Store the capsules at room temperature in a cool, dry place away from heat, moisture, and direct sunlight. Keep the medicine in its original packaging and out of the reach of children.

⭐ Conclusion

Infigratinib 25 mg and 100 mg are targeted therapies for eligible patients with FGFR2-altered cholangiocarcinoma. When used under specialist supervision and guided by appropriate genetic testing, Infigratinib can help slow disease progression and improve treatment outcomes. Always use this medication exactly as prescribed by your healthcare provider.